Semarion
Pre-clinicalSemaCyte microcarriers turn adherent cells into barcoded, assay-ready reagents for higher throughput & standardisation on existing equipment.
Founded
2019
Focus
Drug DeliveryCell TherapySynthetic Biology
About
SemaCyte microcarriers turn adherent cells into barcoded, assay-ready reagents for higher throughput & standardisation on existing equipment.
Funding History
2Total raised: $3.3M
Seed$2.5MCambridge EnterpriseJun 15, 2021
Grant$800KInnovate UKOct 15, 2020
Company Info
TypePrivate
Founded2019
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile